These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2909744)

  • 1. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
    Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
    J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists.
    Carceller E; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1992 Feb; 35(4):676-83. PubMed ID: 1542094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
    Grue-Sørensen G; Nielsen IM; Nielsen CK
    J Med Chem; 1988 Jun; 31(6):1174-8. PubMed ID: 3373485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
    Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.
    Bartrolí J; Carceller E; Merlos M; García-Rafanell J; Forn J
    J Med Chem; 1991 Jan; 34(1):373-86. PubMed ID: 1992139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1986 Mar; 29(3):328-33. PubMed ID: 3950913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
    Trova MP; Wissner A; Carroll ML; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Kohler CA
    J Med Chem; 1993 Mar; 36(5):580-90. PubMed ID: 8496938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of platelet activating factor (PAF) antagonists. II. Modification of the 2-position of the glycerol backbone of PAF-sulfonamide isosteres.
    Tsuri T; Matsui T; Haga N; Kamata S; Hagishita S; Takahashi K; Kakushi H; Uchida K; Hatakeyama H; Kurosawa A
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):85-95. PubMed ID: 1576692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship].
    Kertscher HP; Schwabe W; Grupe R
    Pharmazie; 1993 Jan; 48(1):23-6. PubMed ID: 8460172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1181-7. PubMed ID: 4032422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
    Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group.
    Wissner A; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1365-7. PubMed ID: 4032438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactone and cyclic ether analogues of platelet-activating factor. Synthesis and biological activities.
    Miyazaki H; Ohkawa N; Nakamura N; Ito T; Sada T; Oshima T; Koike H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2379-90. PubMed ID: 2605681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.
    Wichrowski B; Jouquey S; Broquet C; Heymans F; Godfroid JJ; Fichelle J; Worcel M
    J Med Chem; 1988 Feb; 31(2):410-5. PubMed ID: 3339611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
    Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
    J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
    Hofmann B; Ostermann G; Kertscher HP; Till U
    Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.
    Wissner A; Carroll ML; Green KE; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Wrenn S; Kohler CA
    J Med Chem; 1992 May; 35(9):1650-62. PubMed ID: 1578493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.